Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 15
Review
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,291 | Dovepress* | 8,420+ | 2,150 | 10,570 | |
| PubMed Central* | 5,871 | 639 | 6,510 | ||
| Totals | 14,291 | 2,789 | 17,080 | ||
| *Since 31 January 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar